FDA Drug information
BRIXADI
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- BRIXADI BUPRENORPHINE 128 mg/.36mL Braeburn Inc.
- BRIXADI BUPRENORPHINE 16 mg/.32mL Braeburn Inc.
- BRIXADI BUPRENORPHINE 24 mg/.48mL Braeburn Inc.
- BRIXADI BUPRENORPHINE 32 mg/.64mL Braeburn Inc.
- BRIXADI BUPRENORPHINE 64 mg/.18mL Braeburn Inc.
- BRIXADI BUPRENORPHINE 8 mg/.16mL Braeburn Inc.
- BRIXADI BUPRENORPHINE 96 mg/.27mL Braeburn Inc.
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.